Chemical and biological properties of the world's most expensive spice: Saffron

Abstract Saffron (Crocus sativus, L.) is traditionally used as a coloring or flavoring agent, but recent research has shown its potential to promote health. The constituents of interest include crocin, crocetin, picrocrocin, and safranal which have all demonstrated health promoting properties. Previous studies have found that biological activity of saffron constituents alleviate or prevent such health problems as gastric disorders, cardiovascular disease, insulin resistance, depression, premenstrual syndrome, insomnia, and anxiety. Saffron also shows promise in the prevention and maintenance of cancer due to its antioxidant properties. The present review article highlights the constituents that are important in the treatment of each disorder as well as the mechanisms. Many of the studies were conducted using purified forms of the constituents or completed on animal subjects. The need for human subjects using saffron in its natural form is evident to determine the possible health benefits of dietary saffron.

[1]  H. Hosseinzadeh,et al.  STUDY OF ANTIDEPRESSANT EFFECT OF AQUEOUS AND ETHANOLIC EXTRACT OF CROCUS SATIVUS IN MICE , 2001 .

[2]  H. Hosseinzadeh,et al.  Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice , 2009, Phytotherapy research : PTR.

[3]  M. Recio,et al.  An Update Review of Saffron and its Active Constituents , 1996 .

[4]  S. Akhondzadeh,et al.  Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. , 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[5]  K. Abe,et al.  Crocin (crocetin di-gentiobiose ester) prevents the inhibitory effect of ethanol on long-term potentiation in the dentate gyrus in vivo. , 1994, The Journal of pharmacology and experimental therapeutics.

[6]  Sushanta K Banerjee,et al.  Crocetin inhibits pancreatic cancer cell proliferation and tumor progression in a xenograft mouse model , 2009, Molecular Cancer Therapeutics.

[7]  H. Hosseinzadeh,et al.  ANTIDEPRESSANT EFFECT OF CROCUS SATIVUS L. STIGMA EXTRACTS AND THEIR CONSTITUENTS, CROCIN AND SAFRANAL, IN MICE , 2004 .

[8]  A. Hensel,et al.  Saffron in phytotherapy: Pharmacology and clinical uses , 2007, Wiener Medizinische Wochenschrift.

[9]  Y. Shoyama,et al.  Membrane associated antitumor effects of crocine-, ginsenoside- and cannabinoid derivates. , 2000, Anticancer research.

[10]  G. Alonso,et al.  Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro. , 1996, Cancer letters.

[11]  L. Sheng,et al.  Suppression of vascular cell adhesion molecule-1 expression by crocetin contributes to attenuation of atherosclerosis in hypercholesterolemic rabbits. , 2005, Biochemical pharmacology.

[12]  K. Mozaffari,et al.  Effects of saffron and its active constituents, crocin and safranal, on prevention of indomethacin induced gastric ulcers in diabetic and nondiabetic rats. , 2009 .

[13]  H. Redkey,et al.  A new approach. , 1967, Rehabilitation record.

[14]  Xiang-chun Shen,et al.  Crocetin Prevents Dexamethasone-Induced Insulin Resistance in Rats , 2005, Planta medica.

[15]  R. D. Crecchio The saffron crocus. , 1960 .

[16]  Gonzalo L. Alonso,et al.  COMPOSITION OF CROCINS AND PICROCROCIN FROM SPANISH SAFFRON (CROCUS SATIVUS L.) , 2001 .

[17]  T. Hill The Contemporary Encyclopedia of Herbs & Spices: Seasonings for the Global Kitchen , 2004 .

[18]  G. Eisenbrand,et al.  Crocus sativus L. , 1992 .

[19]  P. Tarantilis,et al.  Effects of the active constituents of Crocus sativus L., crocins, in an animal model of anxiety. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[20]  H. Tajmir-Riahi,et al.  Crocetin, dimethylcrocetin, and safranal bind human serum albumin: stability and antioxidative properties. , 2007, Journal of agricultural and food chemistry.

[21]  C. Ito,et al.  Pharmacological properties of N-095, a drug containing red ginseng, polygala root, saffron, antelope horn and aloe wood. , 2005, The American journal of Chinese medicine.

[22]  Na Wen,et al.  Influence of Crocetin on experimental atherosclerosis in hyperlipidamic-diet quails. , 2007, European journal of pharmacology.

[23]  K. Abe,et al.  Pharmacological activities of crocin in saffron , 2007, Journal of Natural Medicines.

[24]  H. Pfander,et al.  Isolation and Structure Elucidation of Carotenoid−Glycosyl Esters in Gardenia Fruits (Gardenia jasminoides Ellis) and Saffron (Crocus sativus Linne) , 1996 .

[25]  Fikart I. Abdullaev Cancer Chemopreventive and Tumoricidal Properties of Saffron (Crocus sativus L.) , 2002, Experimental biology and medicine.

[26]  E. Breitmaier Isolation and Structure Elucidation , 2006 .

[27]  Y. S. Lewis,et al.  Saffron (Crocus Sativus Linn.) — Cultivation, processing, chemistry and standardization , 1984 .

[28]  K. Panikkar,et al.  Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. , 1991, Nutrition and cancer.

[29]  J. Iborra,et al.  A non-destructive method to determine the safranal content of saffron (Crocus sativus L.) by supercritical carbon dioxide extraction combined with high-performance liquid chromatography and gas chromatography. , 2000, Journal of biochemical and biophysical methods.

[30]  S. Mousavi,et al.  Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[31]  C. Morin The nature of insomnia and the need to refine our diagnostic criteria. , 2000, Psychosomatic medicine.

[32]  G. Ao,et al.  Preventive effect of crocin in inflamed animals and in LPS-challenged RAW 264.7 cells. , 2009, Journal of agricultural and food chemistry.

[33]  S. Akhondzadeh,et al.  Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: A pilot double-blind randomized trial , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[34]  H. Hosseinzadeh,et al.  ANTIDEPRESSANT EFFECTS OF CROCUS SATIVUS STIGMA EXTRACTS AND ITS CONSTITUENTS, CROCIN AND SAFRANAL, IN MICE , 2004 .

[35]  S. Hagh-Nazari,et al.  SAFFRON AND VARIOUS FRAUD MANNERS IN ITS PRODUCTION AND TRADES , 2007 .

[36]  S. Taylor,et al.  The role of natural color additives in food allergy. , 2001, Advances in food and nutrition research.

[37]  L. Sheng,et al.  Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase. , 2006, European journal of pharmacology.

[38]  H. Riese,et al.  Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. , 1999, Nutrition and cancer.

[39]  S. Mousavi,et al.  Role of caspases and Bax protein in saffron-induced apoptosis in MCF-7 cells. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[40]  R. Jagadeeswaran,et al.  In vitro studies on the selective cytotoxic effect of crocetin and quercetin. , 2000, Fitoterapia.

[41]  S C Nair,et al.  Saffron chemoprevention in biology and medicine: a review. , 1995, Cancer biotherapy.

[42]  Na Wen,et al.  Effect of crocin on experimental atherosclerosis in quails and its mechanisms. , 2005, Life sciences.

[43]  S. Akhondzadeh,et al.  Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] , 2004, BMC complementary and alternative medicine.

[44]  M. Manfait,et al.  Separation of picrocrocin, cis-trans-crocins and safranal of saffron using high-performance liquid chromatography with photodiode-array detection. , 1994, Journal of chromatography. A.

[45]  M Carmona,et al.  A New Approach to Saffron Aroma , 2007, Critical reviews in food science and nutrition.

[46]  B. Ranjbar,et al.  Interaction of saffron carotenoids as anticancer compounds with ctDNA, Oligo (dG.dC)15, and Oligo (dA.dT)15. , 2007, DNA and cell biology.

[47]  S. Akhondzadeh,et al.  Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double‐blind, randomised and placebo‐controlled trial , 2008, BJOG : an international journal of obstetrics and gynaecology.

[48]  N. Karamanos,et al.  Inhibition of breast cancer cell proliferation by style constituents of different Crocus species. , 2007, Anticancer research.

[49]  F. Nabavizadeh,et al.  Saffron (Crocus sativus) increases gastric acid and pepsin secretions in rats: Role of nitric oxide (NO) , 2009 .

[50]  N. Davies,et al.  Effect of drying temperature and air flow on the production and retention of secondary metabolites in saffron. , 2005, Journal of agricultural and food chemistry.

[51]  R. Liu,et al.  Potential synergy of phytochemicals in cancer prevention: mechanism of action. , 2004, The Journal of nutrition.

[52]  N. Bisset Herbal drugs and phytopharmaceuticals , 1994 .

[53]  Growing saffron - the world’s most expensive spice , 2003 .

[54]  S. Akhondzadeh,et al.  Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. , 2005, Journal of ethnopharmacology.

[55]  Gonzalo L. Alonso,et al.  Worldwide market screening of saffron volatile composition , 2009 .

[56]  M. Polissiou,et al.  Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. , 2006, Journal of agricultural and food chemistry.

[57]  S. Akhondzadeh,et al.  Crocus sativus L. in the treatment of mild to moderate depression: a double‐blind, randomized and placebo‐controlled trial , 2004, Phytotherapy research : PTR.

[58]  K. Panikkar,et al.  Antitumour activity of saffron (Crocus sativus). , 1991, Cancer letters.

[59]  Jen-kun Lin,et al.  Inhibition of protein kinase C and proto‐oncogene expression by crocetin in NIH/3T3 cells , 1996, Molecular carcinogenesis.

[60]  A. Assimopoulou,et al.  Radical scavenging activity of Crocus sativus L. extract and its bioactive constituents , 2005, Phytotherapy research : PTR.

[61]  Guanglin Xu,et al.  Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. , 2007, The Journal of nutritional biochemistry.

[62]  H. Hosseinzadeh,et al.  Kaempferol from Saffron Petals , 2003 .

[63]  P. Variyar,et al.  Chemical investigation of gamma-irradiated saffron (Crocus sativus L.). , 2001, Journal of agricultural and food chemistry.

[64]  Moschos G. Polissiou,et al.  Isolation and Identification of the Aroma Components from Saffron (Crocus sativus) , 1997 .